Oral Budesonide Suspension (OBS)
SHP621-302
Phase 3 small_molecule completed
Quick answer
Oral Budesonide Suspension (OBS) for Eosinophilic Esophagitis (EoE) is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Eosinophilic Esophagitis (EoE)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed